Atlas Trials

Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia

Clinical trial NCT06562738 · RECRUITING

Trial details

NCT number
NCT06562738
Sponsor
The Third People's Hospital of Chengdu
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Thrombocytopenia
Start date
2024-06-01
Primary completion
2025-01-31
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.